Panion & BF Biotech Inc (1760) — Working Capital to Net Assets Ratio
Panion & BF Biotech Inc (1760) has a Working Capital to Net Assets ratio of 21.1% as of September 2025. Working capital of NT$401.09 Million (current assets of NT$1.38 Billion minus current liabilities of NT$982.84 Million) is measured against net assets of NT$1.90 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Panion & BF Biotech Inc (1760) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Panion & BF Biotech Inc Working Capital to Net Assets (2009–2024)
This chart shows how Panion & BF Biotech Inc's Working Capital to Net Assets ratio has evolved across 16 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 21.1%, reflecting working capital of NT$401.09 Million against net assets of NT$1.90 Billion TWD. Check Panion & BF Biotech Inc tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Panion & BF Biotech Inc (2009–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Panion & BF Biotech Inc from 2009 to 2024, covering 16 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Panion & BF Biotech Inc.
| Year | WC/NA Ratio | Working Capital (TWD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 25.1% | NT$482.99 Million | NT$1.92 Billion | NT$1.51 Billion | NT$1.03 Billion | ▲ +2.8 pp |
| 2023 | 22.3% | NT$425.79 Million | NT$1.91 Billion | NT$1.48 Billion | NT$1.05 Billion | ▼ -1.5 pp |
| 2022 | 23.8% | NT$477.71 Million | NT$2.01 Billion | NT$1.40 Billion | NT$921.58 Million | ▼ -3.8 pp |
| 2021 | 27.6% | NT$534.04 Million | NT$1.93 Billion | NT$1.27 Billion | NT$740.49 Million | ▼ -13.4 pp |
| 2020 | 41.0% | NT$508.36 Million | NT$1.24 Billion | NT$1.45 Billion | NT$946.01 Million | ▼ -20.7 pp |
| 2019 | 61.6% | NT$838.17 Million | NT$1.36 Billion | NT$1.23 Billion | NT$392.17 Million | ▼ -7.0 pp |
| 2018 | 68.7% | NT$927.22 Million | NT$1.35 Billion | NT$1.35 Billion | NT$422.23 Million | ▲ +17.3 pp |
| 2017 | 51.3% | NT$428.80 Million | NT$835.25 Million | NT$762.74 Million | NT$333.94 Million | ▲ +4.8 pp |
| 2016 | 46.5% | NT$374.91 Million | NT$806.41 Million | NT$685.93 Million | NT$311.02 Million | ▼ -1.2 pp |
| 2015 | 47.7% | NT$369.35 Million | NT$775.03 Million | NT$684.91 Million | NT$315.56 Million | ▼ -0.6 pp |
| 2014 | 48.3% | NT$343.27 Million | NT$710.84 Million | NT$649.35 Million | NT$306.08 Million | ▼ -5.0 pp |
| 2013 | 53.3% | NT$349.75 Million | NT$656.55 Million | NT$607.50 Million | NT$257.74 Million | ▲ +19.6 pp |
| 2012 | 33.7% | NT$93.94 Million | NT$278.86 Million | NT$537.85 Million | NT$443.90 Million | ▼ -9.5 pp |
| 2011 | 43.1% | NT$128.12 Million | NT$296.98 Million | NT$546.83 Million | NT$418.71 Million | ▼ -21.2 pp |
| 2010 | 64.3% | NT$194.06 Million | NT$301.62 Million | NT$537.10 Million | NT$343.04 Million | ▲ +36.2 pp |
| 2009 | 28.2% | NT$91.47 Million | NT$324.61 Million | NT$568.66 Million | NT$477.19 Million | — |